The setback casts doubt on the potential of GLP-1 drugs, primarily used for weight loss and diabetes, to offer treatments for brain diseases like Alzheimer's or Parkinson's.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback